Myoepithelial progenitors as founder cells of hyperplastic human breast lesions upon PIK3CA transformation.

Autor: Goldhammer N; Department of Cellular and Molecular Medicine, University of Copenhagen, Copenhagen N, Denmark.; Novo Nordisk Foundation Center for Stem Cell Biology, University of Copenhagen, Copenhagen N, Denmark., Kim J; Department of Cellular and Molecular Medicine, University of Copenhagen, Copenhagen N, Denmark.; Novo Nordisk Foundation Center for Stem Cell Biology, University of Copenhagen, Copenhagen N, Denmark., Villadsen R; Department of Cellular and Molecular Medicine, University of Copenhagen, Copenhagen N, Denmark., Rønnov-Jessen L; Section for Cell Biology and Physiology, Department of Biology, University of Copenhagen, Copenhagen Ø, Denmark., Petersen OW; Department of Cellular and Molecular Medicine, University of Copenhagen, Copenhagen N, Denmark. owp@sund.ku.dk.; Novo Nordisk Foundation Center for Stem Cell Biology, University of Copenhagen, Copenhagen N, Denmark. owp@sund.ku.dk.
Jazyk: angličtina
Zdroj: Communications biology [Commun Biol] 2022 Mar 10; Vol. 5 (1), pp. 219. Date of Electronic Publication: 2022 Mar 10.
DOI: 10.1038/s42003-022-03161-x
Abstrakt: The myoepithelial (MEP) lineage of human breast comprises bipotent and multipotent progenitors in ducts and terminal duct lobular units (TDLUs). We here assess whether this heterogeneity impacts on oncogenic PIK3CA transformation. Single cell RNA sequencing (scRNA-seq) and multicolor imaging reveal that terminal ducts represent the most enriched source of cells with ductal MEP markers including α-smooth muscle actin (α-SMA), keratin K14, K17 and CD200. Furthermore, we find neighboring CD200 high and CD200 low progenitors within terminal ducts. When sorted and kept in ground state conditions, their CD200 low and CD200 high phenotypes are preserved. Upon differentiation, progenitors remain multipotent and bipotent, respectively. Immortalized progenitors are transduced with mutant PIK3CA on an shp53 background. Upon transplantation, CD200 low MEP progenitors distinguish from CD200 high by the formation of multilayered structures with a hyperplastic inner layer of luminal epithelial cells. We suggest a model with spatially distributed MEP progenitors as founder cells of biphasic breast lesions with implications for early detection and prevention strategies.
(© 2022. The Author(s).)
Databáze: MEDLINE
Externí odkaz:
Nepřihlášeným uživatelům se plný text nezobrazuje